Laos records 285 new Covid-19 cases

Laos has confirmed 285 new Covid-19 cases over the past 24 hours, bringing the total to 32,314 including 7,005 active cases and 40 deaths, according to the National Taskforce Committee for Covid-19 Prevention and Control.

Of the new confirmed cases, 280 were classified as local infections mostly in Luang Prabang 101, Vientiane 83, Khammuan 24, Vientiane (province) 17, Savannakhet 15, Saravan 14, and Champassak 12.

Luang Namtha reported eight domestic cases as Bokeo did three, and Oudomxay, Xaysomboun and Borikhamxay reported one each.

Five new imported cases were reported with two each in Xayabury and Vientiane, and one in Savannakhet.

Director General of the Department of Communicable Disease Control, Ministry of Health, Dr Rattanaxay Phetsouvanh told a press conference today that the infections were detected among 3,637 people tested for Covid-19 yesterday.

Yesterday also witnessed 517 patients discharged from hospital.

Source: Lao News Agency

Laos records 296 new Covid-19 cases, two new deaths

Some 296 new cases of Covid-19 and two new deaths attributed to the virus have been recorded nationwide over the previous 24 hours, bringing the total to 32,029 including 40 deaths.

The National Taskforce Committee for Covid-19 Prevention and Control told a press conference today that of the new confirmed cases, 283 were classified as local infections and 13 as imported cases.

Most local infections were recorded in Vientiane 105, Luang Prabang 49,Vientiane (province) 47, Champassak 24, Bokeo 20, Khammuan 15, Saravan 12, Savannakhet eight, Borikhamxay two, and Luang Namtha and Xayaboury one each

Source: Lao News Agency

Facebook Plans to Hire 10,000 in EU to Build ‘Metaverse’

Facebook says it plans to hire 10,000 workers in the European Union over the next five years to work on a new computing platform.

The company said in a blog post Sunday that those high-skilled workers will help build “the metaverse,” a futuristic notion for connecting people online that encompasses augmented and virtual reality.

Facebook executives have been touting the metaverse as the next big thing after the mobile internet as they also contend with other matters such as antitrust crackdowns, the testimony of a whistleblowing former employee and concerns about how the company handles vaccine-related and political misinformation on its platform.

In a separate blog post Sunday, the company defended its approach to combating hate speech, in response to a Wall Street Journal article that examined the company’s inability to detect and remove hateful and excessively violent posts.

Source: Voice of America

In Quiet Debut, Alzheimer’s Drug Finds Questions, Skepticism

The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by questions about its price and how well it works.

Several major medical centers remain undecided on whether to use Biogen’s Aduhelm, which is recommended for early stages of the disease. Big names like the Cleveland Clinic and Mass General Brigham in Boston say they’ll pass on it for now.

One neurology practice has even banned the company’s sales reps from its offices, citing concerns about the drug and its price, which can climb past $50,000 annually.

Many doctors say they need to learn more about how Aduhelm works and what will be covered before they decide whether to offer it. That might take several months to sort out. Even then, questions may linger.

“The drug won’t be for everybody, even with access,” said Salim Syed, an analyst who covers Biogen for Mizuho Securities USA.

Syed estimates that only around one-tenth of the people diagnosed with early-stage Alzheimer’s may wind up taking Aduhelm chronically, especially if regulators approve similar treatments from Biogen’s competitors.

Biogen, which reports third-quarter financial results Wednesday, is not saying how many people have received the drug since it was approved on June 7. A company executive said last month that Biogen was aware of about 50 sites infusing Aduhelm, far fewer than the 900 the company had said it expected to be ready shortly after regulators approved the drug.

Aduhelm is the first in a line of new drugs that promise to do what no other Alzheimer’s treatment has managed: slow the progress of the fatal brain-destroying disease instead of just managing its symptoms.

“It’s like a breath of fresh air,” said Dr. Stephen Salloway, a Rhode Island neurologist and Biogen consultant who is prescribing the drug. People with Alzheimer’s “know what’s coming, and they want to do whatever they can to stay in the milder stage.”

The U.S. Food and Drug Administration approved Aduhelm despite objections from its own independent advisers, several of whom resigned. The agency later said the drug was appropriate for patients with mild symptoms or early-stage Alzheimer’s.

Aduhelm clears brain plaque thought to play a role in Alzheimer’s disease, and regulators made the call based on study results showing the drug seemed likely to benefit patients.

Biogen, which developed Aduhelm with Japan’s Eisai Co., had halted two studies on the drug due to disappointing results. It later said further analysis showed the treatment was effective at higher doses.

The FDA is requiring Biogen to conduct a follow-up study.

The research Biogen submitted so far doesn’t give doctors as much insight as they would normally have into a drug, said Dr. Brendan Kelley, a neurologist at UT Southwestern Medical Center in Dallas. Its experts are still reviewing Aduhelm.

“Biogen went to the FDA with preliminary data, so it makes it really challenging to know how to navigate,” he said. More complete research would give doctors a better idea for how the drug will work in a broader patient population, Kelley said.

Cost is another concern.

Biogen’s pricing for Aduhelm is “irresponsible and unconscionable,” according to signs posted on office doors for The Neurology Center, a Washington, D.C.-area practice. The signs also refer to Aduhelm as a medication “of dubious effectiveness” and tell Biogen sales reps they are no longer welcomed in the center’s offices.

“As physicians we feel compelled to speak out and protest BIOGEN’s actions,” one of the signs reads.

Neurology Center CEO Wendy Van Fossen said the signs went up in July, but she declined to elaborate on why they were posted.

A Biogen spokeswoman said in an email that it was disappointing that some centers are denying access to the drug.

As for Aduhelm’s effectiveness, company data shows that plaque removal “is reasonably likely to predict a clinical benefit,” said Biogen Chief Medical Officer Dr. Maha Radhakrishnan. She said regulators reviewed data from more than 3,000 patients, counting two late-stage studies and earlier research.

Doctors also are worried about whether patients taking Aduhelm will be able to get the regular brain scans needed to monitor their progress on the drug.

Issues with care access weren’t explored in the clinical research, which also involved patients who were generally younger and healthier than those in the broader population, noted Dr. Zaldy Tan, director of the Cedars-Sinai memory and aging program.

The Los Angeles health system is still evaluating Aduhelm. Its committee of experts is considering things like which doctors will prescribe the drug and how to ensure patients are monitored for problems like dizziness or if headaches develop. Bleeding in the brain is another potential side effect.

“Safety and access are real issues that need to be prioritized,” Tan said.

Aduhelm also requires a deeper level of coordination among doctors than other Alzheimer’s treatments, noted Radhakrishnan.

Prescribing doctors have to work with neurologists, radiologists and nurse practitioners to diagnose patients, confirm the presence of plaque in the brain, get them started on the treatment and then monitor them.

“All of this is work in progress,” Radhakrishnan said.

Uncertainty about insurance coverage is another holdup.

Some insurers have decided not to cover the drug. Others, including the major Medicare Advantage insurer Humana, haven’t made a decision yet but are reviewing claims case by case in the meantime.

The federal Medicare program is expected to make a national coverage determination by next spring that will lay out how it handles the drug.

Biogen executives said recently they think most sites that will offer the drug are waiting for clarity on reimbursement, including that Medicare decision.

Medicare’s determination looms large for the Cedars-Sinai experts. Tan said they know they should reach a decision before the Medicare decision prompts more patient inquiries.

He said doctors also realize they aren’t just evaluating Aduhelm: They’re also thinking about how to handle similar treatments that could get FDA approval.

“We want to make sure we get it right,” Tan said.

Source: Voice of America

WeownomyPay: Turning WEOWNS Into a Mass Currency of Kindness

Global has never been more in need of a currency that is for everyone. With WeownomyPay, there are no transaction fees and you can withdraw your money anywhere. The WEOWNS economy is coming to life and it’s time to start paying with compassion.

WeownomyPay

WeownomyPay

DELAWARE CITY, Del., Oct. 15, 2021 (GLOBE NEWSWIRE) — It’s hard to imagine what it would be like if you couldn’t buy anything with money. But this is the reality for 3 billion people around the world, many of whom live in developing countries. This isn’t just a problem of poverty and lack of access to banking services—this also impacts economies and society as a whole. The new digital payment system will be used to make social media transactions and remittance services free of charge for over 1 billion people worldwide. The founder of WeownomyPay Ssemakula Peter Luyima believes that digital currencies are not very useful unless they can connect with mainstream society in some way. The intention is to create a digital currency that connects the cryptocurrency world to what most societies use every day: money.

In today’s digital world, it is no surprise that people are shifting to cryptocurrency. In recent years, more and more companies have begun developing their own cryptocurrencies. But not all of these new currencies have been successful in the market due to a lack of usability. WEOWNS is aiming to change this by providing an alternative form of payment for social media platforms, remittance transactions and Debt Free Personal Economic Security Program with a unique payment method once it’s officially rolled out, with an estimated $5 billion in transactions anticipated by May 2022

The idea of paying for something and then getting paid back for it is what is unique about WeownomyPay. This revolutionary new payment system eliminates all fees associated with making payments through credit cards or wire transfers, giving people a convenient way to pay without incurring any extra costs.

The People Powered WEOWNS

In an era of globalization, with a steadily growing population and increasing cost of living around the world, the demand for a new payment system that benefits everyone is vital. With this in mind, WEOWNOMY came up with an innovative solution to meet these needs: WeownomyPay.

The design is geared towards: 1] providing debt-free personal economic security for everyone; 2] eliminating transaction fees; 3] rewarding remittance transactions with an extra amount of WEOWNS; 4] creating strategic partnerships that will help build key African Unity Initiatives powered by Pan African Peoples Alliance and Pan African Peoples Accord..

In the next 20 years, more than 50% of the global population will live in urban areas. A consequence of this is that people will be less connected to each other and it will become increasingly difficult for people to find empathy and compassion in a world where they are surrounded by strangers.

WeownomyPay’s vision is for WEOWNS, the currency of kindness, to complement fiat currencies, not compete with them; a key strategy is to build personal sustainable economic lives using Weownomy social media platform to enable millions of users and WeownomyChat in order for the network to reach significant scale and large volume of transactions made in WEOWNS.

One Way to Keep the Wealth in Your Own Country

Many developing countries have currencies that are volatile and subject to being devalued. WeownomyPay is a project aiming to solve this problem by providing access to the national currency of the country in which they reside, no matter where they are. WEOWNS will be fully backed by remittance transactions or Weownomy social media user paid online activities for using the platform denominated in WEOWNS to be represented in any fiat currencies.

The United States has a $19 trillion dollar debt. But what if there was a way to keep the wealth in your own country? What if people and businesses in regions whose local currencies have WEOWNS users on the WeownomyPay network could directly access their national currency without any bank intermediaries or exchange rates, but with full confidence that each WEOWNS will be fully backed by the people using WeownomyPay network, which will consist of remittance transactions or Weownomy social media users. It has an ambitious goal to be one of the leading digital currencies in usage, transaction volume and value worldwide.

WEOWNOMYPAY is a unique idea to help build an economy with your country’s own currency. It will allow people and businesses in the regions whose local currencies have WEOWNS users on the WeownomyPay network to directly access their national currency. “WEOWNOMYPAY allows for everyone, no matter where they are, to keep wealth within their own country without having to use any other form of money.” Ssemakula Luyima Peter

WEOWNS Are Not Designed to Replace Local Currencies

The global currency WEOWNS are not designed to replace the local currencies in developing nations but could serve as a complementary to the more established financial services that make up 98% of the developing nations. This will target personal and corporate digital wallets that pay bills, goods and services, debt-free personal economic security program. WeownomyPay will hand out $170 Million in digital WEOWNS via Virtual Wedding Crypto Expo in October 2021 and expects a wide-scale test during WeownomyChat launch in November 2021.

The first user owned payment processor to work with WEOWNS currency trials that will allow users to link their accounts with WEOWNS digital currency. Weownomy will distribute several millions dollars’ worth of WEOWNS through WeownomyPay that is connected to an acquirer bank. These tests are intended to allow users to buy products from participating business entities and WeownomyChat marketplace.

WEOWNMYPAY: A LINK TO THE WEOWNS ECONOMY.

The WeownomyPay inclusion shows that the new crypto currency has opened a payment link interface to the ecosystem of internet payment platforms, which could broaden the online application of WEOWNS digital currency in such scenarios as e-commerce, social networks and online-to-offline business. It will attract more merchants to open payment channels for the digital currency, helping leverage the digital WEOWNS role as people’s currency.

The new, blockchain-based digital currency WEOWNS is set to launch in October 2021 (to be announced), with over 100,000 co-owners to sign up for the tests. The system will be distributing 10 million digital WEOWNS “on WEOWNS Wedding day” which are worth $170 Million at current WEOWNS prices. But WEOWNS has one thing no other crypto currency does: it’s all about community ownership. It will not be long before there are more than one billion co-owners around the world who want in on this great opportunity.

Weownomy accelerates its efforts to widely distribute its digital people’s currency of kindness before the WeownomyChat launch; the initiative is a historic initiative to launch people’s monetary kindness system. Once the digital WEOWNS is in wide circulation, it will likely power the digital payment operations of social media, remittance transactions and Debt Free Personal Economic Security Program. The History of Kindness is about to Be Written.

Kindness is the currency of people’s power. It fuels all things that humans care about, whether it be financial or emotional prosperity, health and happiness, relationship bonds with others. Kindness is also the force behind every successful entrepreneurial endeavor. The advent of WeownomyChat will provide a platform for an exponential distribution of kindness in society because WEOWNS are the perfect digital representation of what humans care about most: their own success, health and well-being as well.

About WEOWNS

WEOWNS is a new currency that was created to address the shortcomings of Bitcoin. WEOWNS is designed to be used as an incentive for people who want to do good in their communities, not just mine bitcoins. WEOWNS incentivizes entrepreneurs and users to act with kindness towards one another by building trust through commitments made. This means that any user or entrepreneur who follows the precept should generally be expected to be more successful than otherwise, because they will have earned more WEOWNS.

About Weownomy Platform Corporation

Weownomy Platform Corporation, Incorporated in the State of Delaware https://www.weownomy.global is launching a subscription-based, open and participatory platform. A new redefined social network that facilitates people’s participation in the democratic process of defining their own rules for their future, generating an ownership structure where every person has rights to share in the proceeds generated by this new economy and hence true economic equality.

Media

Ssemakula Peter Luyima

ceo@weownomy.global

President and CEO

Weownomy Platform Corporation

Related Images


Image 1: WeownomyPay

New Digital Payment Processor

This content was issued through the press release distribution service at Newswire.com.

Attachment

Unhappy With Prices, US Ranchers Look to Build Own Meat Plants

Like other ranchers across the country, Rusty Kemp for years grumbled about rock-bottom prices paid for the cattle he raised in central Nebraska, even as the cost of beef at grocery stores kept climbing.

He and his neighbors blamed it on consolidation in the beef industry stretching back to the 1970s that resulted in four companies slaughtering more than 80% of the nation’s cattle, giving the processors more power to set prices while ranchers struggled to make a living. Federal data show that for every dollar spent on food, the share that went to ranchers and farmers dropped from 35 cents in the 1970s to 14 cents recently.

It led Kemp to launch an audacious plan: Raise more than $300 million from ranchers to build a plant themselves, putting their future in their own hands.

“We’ve been complaining about it for 30 years,” Kemp said. “It’s probably time somebody does something about it.”

Crews will start work this fall building the Sustainable Beef plant on nearly 400 acres near North Platte, Nebraska, and other groups are making similar surprising moves in Iowa, Idaho and Wisconsin. The enterprises will test whether it’s really possible to compete financially against an industry trend that has swept through American agriculture and that played a role in meat shortages during the coronavirus pandemic.

The move is well timed, as the U.S. Department of Agriculture is now taking a number of steps to encourage a more diverse supply in the beef industry.

Still, it’s hard to overstate the challenge, going up against huge, well-financed competitors that run highly efficient plants and can sell beef at prices that smaller operators will struggle to match.

‘They’re ready to take a risk’

The question is whether smaller plants can pay ranchers more and still make a profit themselves. An average 620-kilogram steer is worth about $1,630, but that value must be divided between the slaughterhouse, feed lot and the rancher, who typically bears the largest expense of raising the animal for more than a year.

David Briggs, the CEO of Sustainable Beef, acknowledged the difficulty but said his company’s investors remain confident.

“Cattle people are risk takers and they’re ready to take a risk,” Briggs said.

Consolidation of meatpacking started in the mid-1970s, with buyouts of smaller companies, mergers and a shift to much larger plants. Census data cited by the USDA shows that the number of livestock slaughter plants declined from 2,590 in 1977 to 1,387 in 1992. And big processors gradually dominated, going from handling only 12% of cattle in 1977 to 65% by 1997.

Currently four companies — Cargill, JBS, Tyson Foods and National Beef Packing — control more than 80% of the U.S. beef market thanks to cattle slaughtered at 24 plants. That concentration became problematic when the coronavirus infected workers, slowing and even closing some of the massive plants, and a cyberattack last summer briefly forced a shutdown of JBS plants until the company paid an $11 million ransom.

The Biden administration has largely blamed declining competition for a 14% increase in beef prices from December 2020 to August. Since 2016, the wholesale value of beef and profits to the largest processors has steadily increased while prices paid to ranchers have barely budged.

Trying to retain workers with higher pay

The backers of the planned new plants have no intention of replacing the giant slaughterhouses, such as a JBS plant in Grand Island, Nebraska, that processes about 6,000 cattle daily — four times what the proposed North Platte plant would handle.

However, they say they will have important advantages, including more modern equipment and, they hope, less employee turnover thanks to slightly higher pay of more than $50,000 annually plus benefits along with more favorable work schedules. The new Midwest plants are also counting on closer relationships with ranchers, encouraging them to invest in the plants, to share in the profits.

The companies would market their beef both domestically and internationally as being of higher quality than meat processed at larger plants.

Chad Tentinger, who is leading efforts to build a Cattlemen’s Heritage plant near Council Bluffs, Iowa, said he thinks smaller plants were profitable even back to the 1970s but that owners shifted to bigger plants in hopes of increasing profits.

Now, he said, “We want to revolutionize the plant and make it an attractive place to work.”

‘They’re extremely efficient’

Besides paying ranchers more and providing dividends to those who own shares, the hope is that their success will spur more plants to open, and the new competitors will add openness to cattle markets.

Derrell Peel, an agricultural economist at Oklahoma State University, said he hopes they’re right, but noted that research shows even a 30% reduction in a plant’s size will make it far less efficient, meaning higher costs to slaughter each animal.

Unless smaller plants can keep expenses down, they will need to find customers who will pay more for their beef, or manage with a lower profit margin than the big companies.

“We have these very large plants because they’re extremely efficient,” Peel said.

According to the North American Meat Institute, a trade group that includes large and mid-size plants, the biggest challenge will be the shortage of workers in the industry.

It’s unfair to blame the big companies and consolidation for the industry’s problems, said Tyson Fresh Meats group President Shane Miller.

“Many processors, including Tyson, are not able to run their facilities at capacity in spite of ample cattle supply,” Miller told a U.S. Senate committee in July. “This is not by choice: Despite our average wage and benefits of $22 per hour, there are simply not enough workers to fill our plants.”

The proposed new plants come as the USDA is trying to increase the supply chain. The agency has dedicated $650 million toward funding mid-size and small meat and poultry plants and $100 million in loan guarantees for such plants. Also planned are new rules to label meat as a U.S. product to differentiate it from meat raised in other countries.

“We’re trying to support new investment and policies that are going to diversify and address that underlying problem of concentration,” said Andy Green, a USDA senior adviser for fair and competitive markets.

Source: Voice of America